RBRXF — Rhino Biotech Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
- $0.00m
- -$0.53m
Annual cashflow statement for Rhino Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.024 | -0.023 | -0.014 | -0.02 | -0.021 |
| Changes in Working Capital | 0.001 | 0.005 | -0.003 | -0 | 0.005 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.023 | -0.017 | -0.017 | -0.021 | -0.016 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | — | — |
| Financing Cash Flow Items | — | — | — | — | 0.016 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 0 | 0.015 | 0.02 | 0.016 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.023 | -0.017 | -0.002 | -0 | -0 |